Literature DB >> 2075220

Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

S R Kay1.   

Abstract

The positive-negative distinction has emerged as a meaningful basis for understanding the heterogeneity of schizophrenia and treatment alternatives, but its delineation requires carefully devised, well validated techniques. This article considers the psychometric requisites for such an instrument and describes 30 criteria associated with operationalization, scale construction, and standardization. Six prominent positive-negative scales are compared on these criteria, and most are found deficient in terms of: a formalized interview procedure; detailed definitions for levels of symptom severity; exclusion of "secondary" negative symptoms; comparative scales to assess positive symptoms, depression, and global severity of illness; broad sampling of negative symptoms; large scale standardization studies; and determination of multiple facets of reliability and validity. The Positive and Negative Syndrome Scale (PANSS) is described as an effort to approach these principles of test standardization, and its clinical and research applications are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2075220     DOI: 10.1007/BF01064966

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  32 in total

1.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

2.  A Negative Symptom Rating Scale.

Authors:  A C Iager; D G Kirch; R J Wyatt
Journal:  Psychiatry Res       Date:  1985-09       Impact factor: 3.222

3.  Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

Authors:  B Angrist; J Rotrosen; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  High-dose versus low-dose strategies in the treatment of schizophrenia.

Authors:  J M Kane; A Rifkin; M Woerner; G Reardon; D Kreisman; R Blumenthal; M Borenstein
Journal:  Psychopharmacol Bull       Date:  1985

5.  A standardized psychiatric assessment scale for rating chronic psychotic patients.

Authors:  M Krawiecka; D Goldberg; M Vaughan
Journal:  Acta Psychiatr Scand       Date:  1977-04       Impact factor: 6.392

6.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatment.

Authors:  S R Kay; J P Lindenmayer
Journal:  Compr Psychiatry       Date:  1991 Jan-Feb       Impact factor: 3.735

9.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

10.  Positive and negative schizophrenic symptoms, attention, and information processing.

Authors:  B A Cornblatt; M F Lenzenweger; R H Dworkin; L Erlenmeyer-Kimling
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

View more
  27 in total

1.  Validity and reliability of the Polish version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Małgorzata Rzewuska
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

2.  Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning.

Authors:  Felicia Gould; Laura Stone McGuire; Dante Durand; Samir Sabbag; Carlos Larrauri; Thomas L Patterson; Elizabeth W Twamley; Philip D Harvey
Journal:  Neuropsychology       Date:  2015-02-02       Impact factor: 3.295

3.  Trajectories and antecedents of treatment response over time in early-episode psychosis.

Authors:  Stephen Z Levine; J Rabinowitz
Journal:  Schizophr Bull       Date:  2008-10-09       Impact factor: 9.306

4.  Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.

Authors:  P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  Schizophr Bull       Date:  2009-08-07       Impact factor: 9.306

5.  Converting positive and negative symptom scores between PANSS and SAPS/SANS.

Authors:  Theo G M van Erp; Adrian Preda; Dana Nguyen; Lawrence Faziola; Jessica Turner; Juan Bustillo; Aysenil Belger; Kelvin O Lim; Sarah McEwen; James Voyvodic; Daniel H Mathalon; Judith Ford; Steven G Potkin
Journal:  Schizophr Res       Date:  2013-12-11       Impact factor: 4.939

6.  Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

Authors:  Tamara Friedman; Pejman Sehatpour; Elisa Dias; Megan Perrin; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2011-12-21       Impact factor: 13.382

7.  Positive and negative symptoms in families with schizophrenia.

Authors:  A S Bassett; E J Collins; S E Nuttall; W G Honer
Journal:  Schizophr Res       Date:  1993-12       Impact factor: 4.939

Review 8.  Negative symptoms, defect state and Huber's basic symptoms: a comparison of the concepts.

Authors:  J de Leon; W H Wilson; G M Simpson
Journal:  Psychiatr Q       Date:  1991

9.  White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study.

Authors:  Paolo Fusar-Poli; Nicolas Crossley; James Woolley; Francesco Carletti; Rocio Perez-Iglesias; Matthew Broome; Louise Johns; Paul Tabraham; Elvira Bramon; Philip McGuire
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

10.  Computer Vision-Based Assessment of Motor Functioning in Schizophrenia: Use of Smartphones for Remote Measurement of Schizophrenia Symptomatology.

Authors:  Anzar Abbas; Vijay Yadav; Emma Smith; Elizabeth Ramjas; Sarah B Rutter; Caridad Benavidez; Vidya Koesmahargyo; Li Zhang; Lei Guan; Paul Rosenfield; Mercedes Perez-Rodriguez; Isaac R Galatzer-Levy
Journal:  Digit Biomark       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.